ID   SK-RC-7
AC   CVCL_4024
SY   SK-RC 7; SK RC 07; SKRC-7
DR   BTO; BTO:0003195
DR   Wikidata; Q54954640
RX   PubMed=479762;
RX   PubMed=2386958;
RX   PubMed=2784858;
RX   PubMed=6582512;
RX   PubMed=6946460;
RX   PubMed=7017212;
RX   PubMed=27993170;
WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 8
ST   D18S51: 20
ST   D19S433: 14.2,15
ST   D21S11: 28,30
ST   D2S1338: 16,17
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 21
//
RX   PubMed=479762; DOI=10.1084/jem.150.3.564;
RA   Ueda R., Shiku H., Pfreundschuh M., Takahashi T., Li L.T.C.,
RA   Whitmore W.F. Jr., Oettgen H.F., Old L.J.;
RT   "Cell surface antigens of human renal cancer defined by autologous
RT   typing.";
RL   J. Exp. Med. 150:564-579(1979).
//
RX   PubMed=2386958;
RA   Ebert T., Bander N.H., Finstad C.L., Ramsawak R.D., Old L.J.;
RT   "Establishment and characterization of human renal cancer and normal
RT   kidney cell lines.";
RL   Cancer Res. 50:5531-5536(1990).
//
RX   PubMed=2784858; DOI=10.1073/pnas.86.8.2804;
RA   Knuth A., Wolfel T., Klehmann E., Boon T.,
RA   Meyer zum Buschenfelde K.-H.;
RT   "Cytolytic T-cell clones against an autologous human melanoma:
RT   specificity study and definition of three antigens by
RT   immunoselection.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:2804-2808(1989).
//
RX   PubMed=6582512; DOI=10.1073/pnas.81.2.568;
RA   Mattes M.J., Cordon-Cardo C., Lewis J.L. Jr., Old L.J., Lloyd K.O.;
RT   "Cell surface antigens of human ovarian and endometrial carcinoma
RT   defined by mouse monoclonal antibodies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984).
//
RX   PubMed=6946460; DOI=10.1073/pnas.78.8.5122;
RA   Ueda R., Ogata S.-i., Morrissey D.M., Finstad C.L., Szkudlarek J.,
RA   Whitmore W.F. Jr., Oettgen H.F., Lloyd K.O., Old L.J.;
RT   "Cell surface antigens of human renal cancer defined by mouse
RT   monoclonal antibodies: identification of tissue-specific kidney
RT   glycoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:5122-5126(1981).
//
RX   PubMed=7017212; DOI=10.1093/jnci/66.6.1003;
RA   Pollack M.S., Heagney S.D., Livingston P.O., Fogh J.;
RT   "HLA-A, B, C and DR alloantigen expression on forty-six cultured human
RT   tumor cell lines.";
RL   J. Natl. Cancer Inst. 66:1003-1012(1981).
//
RX   PubMed=27993170; DOI=10.1186/s12943-016-0565-8;
RA   Brodaczewska K.K., Szczylik C., Fiedorowicz M., Porta C.,
RA   Czarnecka A.M.;
RT   "Choosing the right cell line for renal cell cancer research.";
RL   Mol. Cancer 15:83.1-83.15(2016).
//